Patents by Inventor Wesley Scott
Wesley Scott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220233110Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.Type: ApplicationFiled: April 14, 2022Publication date: July 28, 2022Applicant: ABBOTT DIABETES CARE INC.Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Michael Love, Phillip Yee, Gary Alan Hayter, R. Curtis Jennewine, Glenn Howard Berman
-
Patent number: 11391723Abstract: The present disclosure provides methods of processing data provided by a transcutaneous or subcutaneous analyte sensor utilizing different algorithms to strike a balance between signal responsiveness accompanied by signal noise and the introduction of error associated with that noise. The methods utilize the strengths of a lag correction algorithm and a smoothing algorithm to optimize the quality and value of the resulting data (glucose concentrations and the rates of change in glucose concentrations) to a continuous glucose monitoring system. Also provided are systems and kits.Type: GrantFiled: August 23, 2018Date of Patent: July 19, 2022Assignee: ABBOTT DIABETES CARE INC.Inventors: Wesley Scott Harper, Erwin Satrya Budiman, Kenneth J. Doniger, Gary Alan Hayter
-
Patent number: 11358511Abstract: The present disclosure is directed toward a storage compartment vehicle (“SCV”) for use in the transport of items for delivery to one or more customers and/or retrieval of items from one or more customers. The SCV may include a plurality of storage compartments that are individually accessible, each of which can contain one or more items. The SCV may navigate to a delivery location and customers may retrieve ordered items from the storage compartments of the SCV. Likewise, customers may return items into storage compartments of the SCV.Type: GrantFiled: January 20, 2020Date of Patent: June 14, 2022Assignee: Amazon Technologies, Inc.Inventors: Wicksell Metellus, Kristopher William Bell, Julius Chen, Wesley Scott Lauka, Ryan Scott Russell
-
Patent number: 11351355Abstract: An intravascular device for pumping blood includes a catheter comprising a membrane chamber located between a proximal end and a distal end of the catheter. An inflatable membrane is disposed within the membrane chamber. The intravascular device includes a first one-way valve and optionally a second one-way valve configured to permit blood flow in a first direction. The first one-way valve may be positioned proximal to the membrane chamber, and the second one-way valve may be positioned distal to the membrane chamber. Methods related to intravascular devices and their respective use are provided.Type: GrantFiled: September 25, 2018Date of Patent: June 7, 2022Assignee: DATASCOPE CORPORATIONInventors: Daniel A. Walters, Abraham Ronai, Wesley Scott Ashton, Paul A. Nigroni
-
Publication number: 20220160866Abstract: The present invention relates to recombinantly constructed polypeptides useful for preparing vaccines, in particular for reducing one or more clinical signs caused by a rotavirus infection. More particular, the present invention is directed to a fusion protein comprising in N- to C-terminal direction (i) an immunogenic fragment of a rotavirus VP8 protein and (ii) an immunoglobulin Fc fragment such as, for example, an IgG Fc fragment, wherein said fusion protein is usable in a method of reducing one or more clinical signs, mortality or fecal shedding caused by a rotavirus infection in swine.Type: ApplicationFiled: October 4, 2021Publication date: May 26, 2022Inventors: David ANSTROM, Abby Rae PATTERSON, Gregory Brian HAIWICK, Wesley Scott JOHNSON, Bryon NICHOLSON, Eric Martin VAUGHN
-
Publication number: 20220160864Abstract: The present invention relates to recombinantly constructed polypeptides useful for preparing vaccines, in particular for reducing one or more clinical signs caused by an infection with at least one pathogen, such as clinical signs caused by a viral infection. More particular, the present invention is directed to a polypeptide comprising a Circoviridae capsid protein linked to a heterologous protein or fragment thereof, and to chimeric virus-like particles composed of such polypeptides. In one example, a fusion protein is provided which comprises PCV2 ORF2 protein linked to an immunogenic fragment of rotavirus VP8 protein, and which is usable for reducing one or more clinical signs, mortality or fecal shedding caused by a rotavirus infection in swine.Type: ApplicationFiled: October 4, 2021Publication date: May 26, 2022Inventors: David ANSTROM, Abby Rae PATTERSON, Gregory Brian HAIWICK, Wesley Scott JOHNSON, Bryon NICHOLSON, Eric Martin VAUGHN
-
Publication number: 20220142524Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.Type: ApplicationFiled: January 20, 2022Publication date: May 12, 2022Applicant: ABBOTT DIABETES CARE INC.Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Michael Love, Phillip Yee, Gary Alan Hayter, R. Curtis Jennewine, Glenn Howard Berman, Erich Yen
-
Publication number: 20220118180Abstract: Methods and systems for delaying alarms that include detecting an analyte level using an analyte sensor; and delaying the annunciation of an analyte alarm after the analyte level crosses an analyte threshold, wherein the delay is based on one or both of (1) a magnitude of difference between the analyte level and the analyte threshold and (2) a duration of time in which the analyte level has crossed the analyte threshold.Type: ApplicationFiled: January 3, 2022Publication date: April 21, 2022Applicant: ABBOTT DIABETES CARE INC.Inventors: Mark Sloan, Marc B. Taub, Gary A. Hayter, Wesley Scott Harper, Erwin S. Budiman, Charles Wei
-
Publication number: 20220110553Abstract: Method and apparatus for optimizing analyte sensor calibration including receiving a current blood glucose measurement, retrieving a time information for an upcoming scheduled calibration event for calibrating an analyte sensor, determining temporal proximity between the current blood glucose measurement and the retrieved time information for the upcoming calibration event, initiating a calibration routine to calibrate the analyte sensor when the determined temporal proximity is within a predetermined time period, and overriding the upcoming scheduled calibration event using the current blood glucose measurement are provided.Type: ApplicationFiled: December 20, 2021Publication date: April 14, 2022Applicant: ABBOTT DIABETES CARE INC.Inventors: Erwin Satrya Budiman, Wesley Scott Harper, Timothy Christian Dunn
-
Patent number: 11298056Abstract: Provided are methods and apparatus for receiving sensor data from an analyte sensor of a sensor monitoring system, processing the received sensor data with time corresponding calibration data, outputting the processed sensor data, detecting one or more adverse conditions associated with the sensor monitoring system, disabling the output of the sensor data during the adverse condition time period, determining that the one or more detected adverse conditions is no longer present in the sensor monitoring system, retrieving the sensor data during the adverse condition time period, processing the retrieved sensor data during the adverse condition time period, and outputting the processed retrieved sensor data.Type: GrantFiled: August 25, 2021Date of Patent: April 12, 2022Assignee: ABBOTT DIABETES CARE INC.Inventor: Wesley Scott Harper
-
Patent number: 11301919Abstract: Systems and methods for improving the efficiency of order fulfillment are disclosed. When fulfilling an order in which substitutions are required, due to unavailability of particular products, the process of contacting the customer and receiving a selection from the customer can be separated from the picking process. The picker can continue to fulfill the order, while an automated system offers alternatives and receives selections from the customer. If appropriate, the substitution can be appended to the picker's list. If the picker has completed the remainder of the order, on the other hand, a new order with the substitution can be created, which can later be aggregated with the original order. A variety of methods can be used to efficiently present substitutions to the customer and receive choices from the customer, including use of imagery of substitute items.Type: GrantFiled: March 10, 2020Date of Patent: April 12, 2022Assignee: Amazon Technologies, Inc.Inventors: Wesley Scott Lauka, Julia Hannah Blum, Taylor Wayne Andrus, Trevor Joseph Allred
-
Publication number: 20220081196Abstract: Manual and automated racking systems and associated methods for loading/unloading glass panels (e.g., insulating glass units (IGU), laminated glass units, glass composites, monolithic glass, and the like) onto/from a transportable rack, and a rack for use with the manual and automated racking systems.Type: ApplicationFiled: September 14, 2021Publication date: March 17, 2022Applicant: Integrated Automation Systems, LLCInventors: Michael E. PETERS, Wesley SCOTT, Michael P. McHUGH
-
Publication number: 20220047812Abstract: Systems for the delivery of insulin to a patient, the system comprising: a continuous glucose sensor configured to provide a glucose level signal representative of sensed glucose; an insulin delivery device configured to deliver insulin in response to delivery control signals at a basal rate and as a bolus; and a controller programmed to receive the sensor glucose level signal and to provide a delivery control signal to an insulin delivery device to suspend a basal delivery rate during the provision of a bolus delivery and to automatically resume a preprogrammed basal delivery rate after a selected event.Type: ApplicationFiled: October 28, 2021Publication date: February 17, 2022Applicant: Abbott Diabetes Care Inc.Inventors: Erwin S. Budiman, Gary A. Hayter, Nathan Crouther, Marc B. Taub, Wesley Scott Harper, Charles Wei
-
Patent number: 11238516Abstract: When a user selects an item at an online marketplace and subsequently provides a search query to the online marketplace, search results or recommendations received from the online marketplace in response to the search query may be displayed based on whether the search results or recommendations would satisfy a requirement established by a source of the selected item. The requirement may relate to a minimum cost threshold, or a minimum number of items. Any search results or recommendations that would, if selected, cause the requirement to be met or exceeded may be preferentially displayed to the user above, or in a more prominent manner, than search results or recommendations that would not, if selected, cause the requirement to be met or exceeded.Type: GrantFiled: June 7, 2019Date of Patent: February 1, 2022Assignee: Amazon Technologies, Inc.Inventors: Vevina Mariam McAllister, Wesley Scott Lauka, Shirley Yiong
-
Patent number: 11232394Abstract: Method and apparatus for controlling delivery of an item. An electronic order specifying the item is received. An item profile for the first item is retrieved. A first instance of positional data for the user and a pattern of delivery preferences of the user are determined. Embodiments determine a first location for delivering the package to the user, based on the item profile, the first instance of positional data for the user and the pattern of delivery preferences of the first user. Shipment of the first item towards the first location is initiated, and based on subsequent network communications with an electronic device associated with the user, a second instance of positional data is determined. Delivery of the first item is facilitated to one of the first location corresponding to the first instance of positional data and a second location corresponding to the instance of positional data.Type: GrantFiled: January 3, 2018Date of Patent: January 25, 2022Assignee: Amazon Technologies, Inc.Inventors: Philip Pinette, Brandon C. Adams, Daniel R. Dole, Kathleen Ann Mitchell Gavenman, Alexis N. Miller, Wesley Scott Lauka, Kristin L. Turner, Joseph D. Wolff
-
Patent number: 11213622Abstract: Methods and systems for delaying alarms that include detecting an analyte level using an analyte sensor; and delaying the annunciation of an analyte alarm after the analyte level crosses an analyte threshold, wherein the delay is based on one or both of (1) a magnitude of difference between the analyte level and the analyte threshold and (2) a duration of time in which the analyte level has crossed the analyte threshold.Type: GrantFiled: September 4, 2019Date of Patent: January 4, 2022Assignee: ABBOTT DIABETES CARE INC.Inventors: Mark Sloan, Marc B. Taub, Gary A. Hayter, Wesley Scott Harper, Erwin S. Budiman, Charles Wei
-
Patent number: 11202592Abstract: Method and apparatus for optimizing analyte sensor calibration including receiving a current blood glucose measurement, retrieving a time information for an upcoming scheduled calibration event for calibrating an analyte sensor, determining temporal proximity between the current blood glucose measurement and the retrieved time information for the upcoming calibration event, initiating a calibration routine to calibrate the analyte sensor when the determined temporal proximity is within a predetermined time period, and overriding the upcoming scheduled calibration event using the current blood glucose measurement are provided.Type: GrantFiled: May 24, 2021Date of Patent: December 21, 2021Assignee: ABBOTT DIABETES CARE INC.Inventors: Erwin Satrya Budiman, Wesley Scott Harper, Timothy Christian Dunn
-
Publication number: 20210379240Abstract: Spray-dried thrombin materials obtained from feedstock solutions comprising less than 5% by weight albumin and excluding trehalose or other excipients as well as methods of manufacturing the thrombin materials and methods of treating bleeding wounds are disclosed. The methods of use include applying reconstituted spray-dried thrombin topically to a bleeding site, optionally in conjunction with gelatin.Type: ApplicationFiled: December 20, 2018Publication date: December 9, 2021Inventors: Alexander Wesley SCOTT, Paul Jeffrey SANDERS, Alyssa SANDERS, Adam Christopher MERCER
-
Publication number: 20210378564Abstract: Provided are methods and apparatus for receiving sensor data from an analyte sensor of a sensor monitoring system, processing the received sensor data with time corresponding calibration data, outputting the processed sensor data, detecting one or more adverse conditions associated with the sensor monitoring system, disabling the output of the sensor data during the adverse condition time period, determining that the one or more detected adverse conditions is no longer present in the sensor monitoring system, retrieving the sensor data during the adverse condition time period, processing the retrieved sensor data during the adverse condition time period, and outputting the processed retrieved sensor data.Type: ApplicationFiled: August 25, 2021Publication date: December 9, 2021Inventor: Wesley Scott Harper
-
Patent number: 11185632Abstract: Systems comprising: an analyte sensor for providing an analyte signal representative of an analyte level; a controller in data communication with the analyte sensor and programmed to provide a recommended medication dose based on the analyte level and a medication type, the controller comprising a user interface for inputting the medication type; and a model-based safety mechanism integrated with the controller for evaluating the recommended medication dose. Wherein the model-based safety mechanism overrides the recommended medication dose and provides a safety medication dose when the model-based safety mechanism detects a risk of insulin deprivation.Type: GrantFiled: March 4, 2020Date of Patent: November 30, 2021Assignee: Abbott Diabetes Care, Inc.Inventors: Erwin S. Budiman, Gary A. Hayter, Nathan Crouther, Marc B. Taub, Wesley Scott Harper, Charles Wei